Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

titled Intercellular TIMP-1-CD63 signalling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells, was based on laboratory experiments using mice ...

Feb. 18, 2025 — Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis.

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Basal cell carcinomas (BCCs) are keratinocyte tumours that resemble the basal layer of the epidermis, and are the most commonly diagnosed human cancer among ... carcinomas in situ, some get ...

Background PARP inhibitors (PARPi) have been licensed for the maintenance therapy of patients with metastatic pancreatic cancer carrying pathogenic germline ... reporter system, in situ proximity ...

After surgical resection of PDA, the nucleoside analogue gemcitabine was widely used as standard adjuvant treatment based on results from the European Study Group for Pancreatic Cancer-3 (ESPAC ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.